OSTEOproSPINE safety
OSTEOproSPINE efficacy
OSTEOproSPINE potential
novel bone-regeneration product OSTEOproSPINE
Novel Bone Regeneration Drug Osteogrow
formation of new bone
functioning new bone
evaluator-blinded clinical trial of OSTEOproSPINE
novel bone regeneration therapy
clinical trials
clinical program
clinical centers
Pain
leading clinical site
recombinant human bone morphogenetic protein
FP7 HEALTH project Osteogrow
autograft
patients
spine’s function
Phase
degenerative disc disorders
degenerative disc disease
fusion of lumbar vertebrae
excellent safety profile
positive outcome of proposed trial
spine’s weight
program consortium
extra-skeletal site
success rate of posterolateral spinal fusion surgery
Therapeutic Solution
distal radius fracture
rhBMP6
allograft
comparison
treatment
population of presumptive cells
ground principle of regenerative medicine
high tibial osteotomy
quality of life
patient’s iliac crest
correct molecular signals
partners
Vienna
Standard of care
evaluation
autologous peripheral blood coagulum
coordinating institution
Grant
Ethics Committee
administration
permissive microenvironment
EU member states
compression resistant matrix
conditional approval
severity
humans